Literature DB >> 33987888

Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1-SSX1 fusions.

Cristina R Antonescu1, Andrew E Rosenberg2, Ziyu Xie1, Lei Zhang1, Katharina Anne Perell3, Anand C Loya4.   

Abstract

Undifferentiated sarcomas remain difficult to classify. Despite the remarkable advances in sarcoma classification made by the increased application of RNA sequencing in clinical practice, the unexpected result of a novel gene fusion raises further questions regarding the tumor histogenesis and subclassification. In this study, we present two high grade sarcomas with epithelioid phenotype occurring in the deep-soft tissues (shoulder, thigh) of young adults which based on the non-specific pathologic findings were deemed unclassified and subjected to targeted RNA sequencing for further diagnostic interpretation. The results showed an identical EWSR1 exon 7-SSX1 exon 5 fusion. The breakpoints in both genes represent similar hot spots as seen in Ewing sarcoma and synovial sarcoma, generating a fusion transcript predicted to be in frame, and to retain the same protein domains within the fusion oncoprotein. These results were further confirmed by FISH analysis for both break-apart and fusion come-together assays in both genes. Both tumors showed a round to epithelioid morphology associated with extensive stromal hyalinization and necrosis. One case showed scattered psammomatous calcifications. The tumors shared a similar immunoprofile, including reactivity for EMA, CK, TLE1, BCOR, and CD99, while negative for S100, SOX10, CD34, SMA, and desmin. Both cases showed MUC4 positivity (one diffuse, one patchy), while one case showed patchy ALK positivity. One patient developed lymph node metastases, while the other showed no evidence of disease at 6-month follow-up. Neither case fit in any known pathologic categories. Larger series are needed to interrogate if the presence of EWSR1-SSX1 fusion defines a novel pathologic entity of a sarcoma with epithelioid cytomorphology, sclerotic stroma, and epithelial differentiation immunohistochemically.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  EWSR1; SSX1; sarcoma; undifferentiated

Mesh:

Substances:

Year:  2021        PMID: 33987888      PMCID: PMC8266753          DOI: 10.1002/gcc.22970

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   4.263


  22 in total

1.  Undifferentiated round cell sarcomas with novel SS18-POU5F1 fusions.

Authors:  Cristina R Antonescu; Narasimhan P Agaram; Yun-Shao Sung; Lei Zhang; Brendan C Dickson
Journal:  Genes Chromosomes Cancer       Date:  2020-07-06       Impact factor: 5.006

2.  Anchored multiplex PCR for targeted next-generation sequencing.

Authors:  Zongli Zheng; Matthew Liebers; Boryana Zhelyazkova; Yi Cao; Divya Panditi; Kerry D Lynch; Juxiang Chen; Hayley E Robinson; Hyo Sup Shim; Juliann Chmielecki; William Pao; Jeffrey A Engelman; A John Iafrate; Long Phi Le
Journal:  Nat Med       Date:  2014-11-10       Impact factor: 53.440

3.  Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.

Authors:  Elsa Arbajian; Florian Puls; Linda Magnusson; Khin Thway; Cyril Fisher; Vaiyapuri P Sumathi; Johnbosco Tayebwa; Karolin H Nord; Lars-Gunnar Kindblom; Fredrik Mertens
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

4.  EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.

Authors:  Cristina R Antonescu; Lei Zhang; Ning-En Chang; Bruce R Pawel; William Travis; Nora Katabi; Morris Edelman; Andrew E Rosenberg; G Petur Nielsen; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

5.  A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.

Authors:  Carlos Prieto-Granada; Lei Zhang; Hsiao-Wei Chen; Yun-Shao Sung; Narasimhan P Agaram; Achim A Jungbluth; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2014-09-18       Impact factor: 5.006

6.  Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.

Authors:  Florian Puls; Abbas Agaimy; Uta Flucke; Thomas Mentzel; Vaiyapuri P Sumathi; Marieke Ploegmakers; Robert Stoehr; Lars-Gunnar Kindblom; Magnus Hansson; Saskia Sydow; Elsa Arbajian; Fredrik Mertens
Journal:  Am J Surg Pathol       Date:  2020-05       Impact factor: 6.394

Review 7.  Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes.

Authors:  Fredrik Mertens; Cristina R Antonescu; Felix Mitelman
Journal:  Genes Chromosomes Cancer       Date:  2015-12-18       Impact factor: 5.006

8.  Malignant Ewing-Like Neoplasm With an EWSR1-KLF15 Fusion: At the Crossroads of a Myoepithelial Carcinoma and a Ewing-Like Sarcoma. A Case Report With Treatment Options.

Authors:  Todd M Stevens; Morad Qarmali; Diana Morlote; Fady M Mikhail; Jeffrey Swensen; Zoran Gatalica; Gene P Siegal; Robert M Conry
Journal:  Int J Surg Pathol       Date:  2018-02-01       Impact factor: 1.271

9.  A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas.

Authors:  F L Lim; M Soulez; D Koczan; H J Thiesen; J C Knight
Journal:  Oncogene       Date:  1998-10-15       Impact factor: 9.867

10.  Sarcoma classification by DNA methylation profiling.

Authors:  Christian Koelsche; Daniel Schrimpf; Damian Stichel; Martin Sill; Felix Sahm; David E Reuss; Mirjam Blattner; Barbara Worst; Christoph E Heilig; Katja Beck; Peter Horak; Simon Kreutzfeldt; Elke Paff; Sebastian Stark; Pascal Johann; Florian Selt; Jonas Ecker; Dominik Sturm; Kristian W Pajtler; Annekathrin Reinhardt; Annika K Wefers; Philipp Sievers; Azadeh Ebrahimi; Abigail Suwala; Francisco Fernández-Klett; Belén Casalini; Andrey Korshunov; Volker Hovestadt; Felix K F Kommoss; Mark Kriegsmann; Matthias Schick; Melanie Bewerunge-Hudler; Till Milde; Olaf Witt; Andreas E Kulozik; Marcel Kool; Laura Romero-Pérez; Thomas G P Grünewald; Thomas Kirchner; Wolfgang Wick; Michael Platten; Andreas Unterberg; Matthias Uhl; Amir Abdollahi; Jürgen Debus; Burkhard Lehner; Christian Thomas; Martin Hasselblatt; Werner Paulus; Christian Hartmann; Ori Staszewski; Marco Prinz; Jürgen Hench; Stephan Frank; Yvonne M H Versleijen-Jonkers; Marije E Weidema; Thomas Mentzel; Klaus Griewank; Enrique de Álava; Juan Díaz Martín; Miguel A Idoate Gastearena; Kenneth Tou-En Chang; Sharon Yin Yee Low; Adrian Cuevas-Bourdier; Michel Mittelbronn; Martin Mynarek; Stefan Rutkowski; Ulrich Schüller; Viktor F Mautner; Jens Schittenhelm; Jonathan Serrano; Matija Snuderl; Reinhard Büttner; Thomas Klingebiel; Rolf Buslei; Manfred Gessler; Pieter Wesseling; Winand N M Dinjens; Sebastian Brandner; Zane Jaunmuktane; Iben Lyskjær; Peter Schirmacher; Albrecht Stenzinger; Benedikt Brors; Hanno Glimm; Christoph Heining; Oscar M Tirado; Miguel Sáinz-Jaspeado; Jaume Mora; Javier Alonso; Xavier Garcia Del Muro; Sebastian Moran; Manel Esteller; Jamal K Benhamida; Marc Ladanyi; Eva Wardelmann; Cristina Antonescu; Adrienne Flanagan; Uta Dirksen; Peter Hohenberger; Daniel Baumhoer; Wolfgang Hartmann; Christian Vokuhl; Uta Flucke; Iver Petersen; Gunhild Mechtersheimer; David Capper; David T W Jones; Stefan Fröhling; Stefan M Pfister; Andreas von Deimling
Journal:  Nat Commun       Date:  2021-01-21       Impact factor: 17.694

View more
  1 in total

Review 1.  The Molecular Biology of Soft Tissue Sarcomas: Current Knowledge and Future Perspectives.

Authors:  Julien Vibert; Sarah Watson
Journal:  Cancers (Basel)       Date:  2022-05-22       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.